Altimmune
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $5 | $5 | $5 | $5 |
Gross Profit | -25 | 5 | 5 | 5 |
EBITDA | -22,922 | -20,226 | -23,146 | -22,802 |
EBIT | -22,952 | -20,255 | -23,179 | -22,839 |
Net Income | -22,146 | -19,575 | -23,180 | -22,845 |
Net Change In Cash | 5 | 5 | 5 | 5 |
Free Cash Flow | -19,360 | -16,840 | -18,265 | -27,118 |
Cash | 183,105 | 49,104 | 36,926 | 31,474 |
Basic Shares | 81,477 | 75,547 | 71,260 | 71,084 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $20 | $426 | $-68 | $4,410 |
Gross Profit | 20 | -51 | -568 | -69,431 |
EBITDA | -94,812 | -87,935 | -84,402 | -96,533 |
EBIT | -95,050 | -88,412 | -84,902 | -97,084 |
Net Income | -95,059 | -88,447 | -84,713 | -97,090 |
Net Change In Cash | 20 | 426 | -68 | 4,410 |
Cost of Revenue | 74,382 | |||
Free Cash Flow | -79,848 | -75,857 | -62,712 | -90,549 |
Cash | 36,926 | 135,117 | 111,097 | 190,300 |
Basic Shares | 71,003 | 53,246 | 46,926 | 41,283 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.27 |
2025-03-31 | -$0.26 |
2024-12-31 | -$0.33 |
